Back to News

Khadam Goes International

Khadam Goes Global: Massive Box Office Hit Launches Full-Scale International Rollout

Following its highly anticipated initial release across Malaysia and Brunei on June 11, 2026,

the 1950s-set cultural horror film rapidly crossed the RM4 million mark in cumulative ticket

sales. This stellar domestic momentum was fueled by an explosive opening week, where

the movie brought in an impressive RM2.6 million in just its first seven days, proving that

local storytelling can dominate multiplexes even alongside major Hollywood blockbusters.

Capitalizing on this massive home-ground success, the production officially launched its

overseas territorial expansion into broader Southeast Asian markets. The film successfully

held its commercial theatrical debut in Cambodia on July 27, 2026, quickly followed by a

wide rollout in Singapore on August 27, 2026. Exceptional word-of-mouth and positive

critical consensus in both regions continue to drive strong international ticket sales,

establishing the film as a highly lucrative cross-border entity.

The movie’s global footprint is set to widen significantly with its largest regional market

destination yet: an official theatrical launch across Indonesia scheduled for September 16,

2026. This highly anticipated expansion is heavily backed by prominent Indonesian

co-producers Magma Entertainment and VMS Studios, and stars top Indonesian horror icon

Aghniny Haque in her Malaysian cinematic debut—a strategic regional collaboration that

film trade experts project will massively amplify the movie’s total box office revenue.

Beyond Southeast Asia, Khadam is also slated to expand its reach deeper into East Asia

with a wide theatrical premiere in Hong Kong locked in for October 8, 2026. The upcoming

Hong Kong release will be spearheaded by its major early investor partner, Sil-Metropole

Organisation, finalizing a comprehensive global rollout plan that places the Malaysian horror

thriller firmly onto the competitive international stage.